WinterLight Labs
Edit

WinterLight Labs

http://www.winterlightlabs.com/
Last activity: 14.12.2022
Active
Categories: Artificial IntelligenceComputerContentHealthTechLearnResearchScienceSoftwareTechnology
Like a lighthouse providing early warning in the dark of night, changes in language can signal cognitive decline decades before symptoms of dementia become apparent. Currently, over 47.5 million individuals in the world have dementia, and that number is expected to triple by 2050.

At WinterLight Labs, we build technology that can quickly and accurately detect signs of cognitive impairment from a sample of speech. A short 1-5 minute snippet of speech can paint a picture about the speaker's cognitive state, including lexical diversity, syntactic complexity, semantic content, and acoustics. The technology can detect the presence of Alzheimer's Disease with 82% accuracy and aphasia with 100% accuracy.

Our software is based on years of experience and academic, peer-reviewed research. Our team continues to actively publish in computer science and neuroscience journals and conferences.
Followers
866
Followers
1.44K
Website visits
8.9K /mo.
Mentions
13
Location: Canada, Ontario, Toronto
Employees: 11-50
Total raised: $4.23M
Founded date: 2015

Investors 4

Funding Rounds 1

DateSeriesAmountInvestors
19.11.2019-$4.23M-

Mentions in press and media 13

DateTitleDescription
14.12.2022Ваш путеводитель по миру NLP (обработке естественного языка)Как машины обрабатывают и понимают человеческий язык Все, что мы выражаем письменно или устно, несет в себе огромное количество информации. Тема, которую мы выбираем, наш тон, подбор слов - все это добавляет некую информацию, которую можно ...
31.05.2022Depressed? This algorithm can tell from the tone of your voiceMental health issues have come into a clearer focus amid the pandemic. Depression became endemic, but it still too often goes undetected. Even when it does, healthcare providers struggle to meet demand. Two women engineers — both of whom ex...
16.12.2021Today’s Entrepreneur: David Bates, CEO and co-founder of Linus HealthAppreciate today’s fundamentals but design and build from the future Today's entrepreneur is David Bates, CEO and co-founder of digital health company Linus Health, a digital health company revolutionizing industry understanding of mental a...
31.08.2021AI startups claim to detect depression from speech, but the jury’s out on their accuracyA new GamesBeat event is around the corner! Learn more about what comes next. In a 2012 study published in the journal Biological Psychiatry, a team of scientists at the Center for Psychological Consultation (CPC) in Madison, Wisconsin hypo...
31.08.2021AI startups claim to detect depression from speech, but the jury’s out on their accuracyWe are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! In a 2012 study published in the journal Biologic...
07.01.2020Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disordersPear Therapeutics has struck a deal to license voice biomarkers to try to improve treatment for patients with illnesses ranging from Alzheimer’s to insomnia and substance use disorder. In a flurry of announcements Tuesday, the Boston-based ...
25.11.2019Today in funding ($10.26 million): Winterlight Labs, CascaTwo Canadian startups have announced fresh funding rounds to fuel their growth. Here’s the latest on who raised how much, from whom, and what they’ll be putting the new funds toward. Winterlight Labs raises $5.6 million CAD in Series A fund...
19.11.2019Winterlight Labs gets $4.23Mn Investment to Scale Healthtech Services in Morocco & EuropeWinterlight Labs, a health-tech company based in Toronto has raised $4.3 million from Hikma Ventures. The fund will be used to extend its technology that combats various psychological diseases in Africa & Europe. Winterlight Labs Inc wa...
19.11.2019Winterlight Labs Raises CAD 5.6M in FundingWinterlight Labs Inc., a Toronto-based developer of AI vocal technology to detect central nervous system disorders and track efficacy of treatments, raised CAD 5.6m in funding. The round was led by Hikma Pharmaceuticals PLC (LSE: HIK) (NASD...
18.11.2019Speech AI-enabled cognitive health company Winterlight Labs scores $4.23M
Show more

Reviews 0

Sign up to leave a review

Sign up Log In